Oak Street Health, Inc.
Oak Street Health, Inc. (OSH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
osh · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Oak Street Health, Inc.You OSH | $9.5B | N/A | — | -$2.21 |
 Blueprint Medicines Corporation BPMC | $8.4B | N/A | — | -$1.07 |
 Cerevel Therapeutics Holdings, Inc. CERE | $8.2B | N/A | — | -$2.67 |
 Catalent, Inc. CTLT | $11.5B | N/A | — | -$5.76 |
 ImmunoGen, Inc. IMGN | $8.7B | N/A | — | -$0.88 |
 Karuna Therapeutics, Inc. KRTX | $12.6B | N/A | — | -$11.73 |
 LHC Group, Inc. LHCG | $5.3B | 82.28x | — | $1.97 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Oak Street Health, Inc. (OSH) measures how much investors pay for each dollar of the company's trailing earnings. OSH's current PE ratio of N/A is calculated by dividing its stock price of $39.00 by its TTM earnings per share of -$2.21.
Frequently asked questions
OSH pe ratio · 6 questionsOSH's current PE ratio is N/A as of 2026-06-09, based on a stock price of $39.00 and TTM EPS of -$2.21. Data sourced from Financial Modeling Prep via OSH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Oak Street Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09